[Report: resuscitation in community opioid overdose ‒ update and complement to INESSS guidance published in 2018 - Cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
Boughrassa F, Moreault B, Lorthios-Guilledroit A
Record ID 32018005238
French
Original Title:
Avis - Réanimation en contexte de surdose d’opioïdes dans la communauté - Mise à jour et complément de l’Avis de l’INESSS publié en 2018 : Réanimation cardiorespiratoire (RCR) dans le contexte de l’administration de naloxone pour surdose d’opioïdes dans la communauté
Authors' objectives:
In 2018, INESSS published a report on best practices regarding CPR in the context of
opioid overdose. However, heterogeneity in opioid overdose resuscitation protocols and
training persists among organizations throughout Quebec. It was against this backdrop
that the group of Québec community organizations represented by the Association
québécoise des centres d'intervention en dépendance (AQCID) and the Table des
organismes montréalais de lutte contre le VIH/Sida (TOMS) asked INESSS to review its
resuscitation protocol in order to determine: 1) the best clinical and organizational
strategies for the resuscitation and administration of naloxone in cases of opioid
overdose in community settings, along with ways in which these strategies can be
adapted to the specific realities of Quebec, and 2) to propose strategies to improve the
applicability and acceptance of these recommended practices.
The purpose of this update is to consider the protocol’s application context, training and
applicability issues, so that anyone who witnesses an opioid overdose can optimally
apply the protocol.
Authors' results and conclusions:
RESULTS (#1 WITH REGARD TO CARDIOPULMONARY RESUSCITATION): No studies comparing CPR maneuvers (ventilation and/or chest compressions) in
the context of opioid overdose were found.
• Guidelines and protocols intended for CPR-trained witnesses who volunteer to
perform it recommend full CPR, which involves both ventilation and chest
compressions.
• The guidelines and committee members consulted recommend chest
compressions alone for untrained witnesses.
• Several Canadian provinces recommend using ventilation alone in cases of opioid
overdose but they do not specify the necessary level of training of overdose
witnesses.
• Certain protocols and input from the committee members suggest that the
ventilation alone would be sufficient in the case of an overdose in presence of a
witness. However, detecting the difference between respiratory arrest and cardiac
arrest may prove challenging for those without proper training.
• The Québec and Nova Scotia protocols recommend the use of chest
compressions alone for non-CPR-trained witnesses.
• A single, simple protocol involving chest compressions alone would be more likely
to be applied by non-CPR-trained witnesses. (#2 WITH REGARD TO NALOXONE ADMINISTRATION – CONDITIONS OF ADMINISTRATION, DOSE AND
CONTENTS OF THE NALOXONE KIT): The evidence shows that intranasal (IN) naloxone appears to be as effective as
intramuscular (IM) naloxone.
• However, IN naloxone is associated with a slower response time in comparison to
IM naloxone and a higher probability that an extra dose will be necessary.
• In Québec, naloxone is available in two forms, IN and IM. However, the IN form is
more commonly dispensed than the IM form, following the preference of the
opioid users. The use of the IN form is widely accepted due to its ease of use, quick
administration, and enhanced safety as it requires minimal handling.
• Naloxone administration should be repeated every three minutes as necessary, if
for instance the initial dose does not generate improvement or if respiratory
depression reoccurs after an initial response.
• Specific informations should be provided to users of IN naloxone during training or
when a kit is provided. First, there is a risk of the product freezing in the winter.
Secondly, the IN spray contains a single dose of naloxone and should not be
tested, as this could result in being unusable in the event of an overdose. Lastly, it
is crucial to consider the possible emotional impact of intervening in an overdose
situation.
• The evidence indicates that a higher dose results in a greater response to
naloxone, reduces the need for a second dose, and improves survival rate.
However, it is also associated with more adverse effects.
• The naloxone kit available for the public should contain at least four doses of
naloxone (usable in two different overdose situations) as well as a barrier mask
with a one-way valve. (#3 WITH REGARD TO INFECTIOUS DISEASE PREVENTION): The stakeholders consulted believe that the protocol should not be altered based
on COVID-19 status or any other suspected infectious disease and that universal
protective material should be provided.
• A good-quality and safe barrier mask with a one-way valve should be used by
CPR-trained individuals when responding to an overdose, since any victim could
potentially infect the witness. (#4 REGARDING THE RESPONSE SEQUENCE IN AN OPIOID OVERDOSE): The initial step noted in the identified resuscitation protocols is to reassure the
victim.
• An overdose witness should have the ability to recognize the signs of overdose.
• It is imperative to continue promoting the utilization of emergency services by
calling 911.
• Fear of police involvement and potential legal consequences can impede the act
of calling 911. Key stakeholders consulted recommend that the Ministère de la
Santé et des Services sociaux, the Ministère de la Sécurité publique and the
Ministère de la Justice reinitiate intersectoral efforts to promote collaboration and
cooperation.
• The current evidence does not suggest that one sequence (naloxone before or
after CPR) is more effective than the other. (#5 WITH REGARD TO OXYGEN ADMINISTRATION): Due to the paucity of scientific literature on the subject, the information regarding
oxygen administration are primarily derived from experiential and contextual data
obtained during consultations, meetings with committee members, and ad hoc
meetings with key informants.
• Although very sparse, the scientific literature suggests that naloxone is
administered in the majority of cases where oxygen was initially provided.
• In Québec, workers at supervised consumption sites are often requested to
reverse overdose effects when medical personnel are not present on the
premises. Certain sites have the capacity to offer oxygen to overdose victims.
• According to some opioid users who utilize supervised consumption sites, oxygen
is preferred to naloxone due to the latter's significant withdrawal effects.
• Administering oxygen prior to the use of naloxone to prevent severe overdose is
consistent with the harm reduction approach underlying the creation of supervised
consumption sites.
• In cases of overdose where the effectiveness of naloxone would have little or no
effect (e.g., opioids mixed with benzodiazepines), it might be more advantageous
to administer oxygen instead of naloxone. (#6 WITH REGARD TO ACCESS TO NALOXONE
): In Québec, the dispensing of naloxone to individuals is limited to certain
community organizations and pharmacies.
• All individuals consulted for this project expressed support for enhancing access
to naloxone, primarily by expanding its availability at various locations and
reducing the stigmatization individuals may face when seeking it.
• Challenges with supply and unequal distribution of naloxone kits are faced by
community pharmacies and organizations in remote areas. (#7 WITH REGARD TO OPIOID OVERDOSE RESUSCITATION TRAINING): The available guidelines recommend that anyone who may witness an opioid
overdose, including psychoactive substance users and relatives, receive
resuscitation training to act in the event of an opioid overdose.
Authors' recommendations:
CARDIOPULMONARY RESUSCITATION
RECOMMENDATION 1 Witnesses not properly trained in CPR – opioid users, relatives
and members of the general public): Witnesses not properly trained in CPR, e.g., opioid users, relatives, members of the general
public, should respond to suspected opioid overdose by performing only chest compressions. RECOMMENDATION 2 CPR-TRAINED COMMUNITY ORGANIZATION WORKERS): CPR-trained workers at selected community organizations should perform chest
compressions and provide ventilation (full cardiopulmonary resuscitation) in the event of a
suspected opioid overdose. NALOXONE ADMINISTRATION
RECOMMENDATION 3 Conditions of naloxone administration): Community organizations and pharmacies designated as dispensers of naloxone directly to
individuals should provide either intranasal (IN) or intramuscular (IM) naloxone, depending on
the individual's preference.
Authors' methods:
For this request, a rapid review of the scientific and grey literature was conducted in
addition to consulting with various stakeholders, including experts, workers, users, and
close relatives. The collected scientific, contextual, and experiential data were analyzed
to draw key findings and recommendations. These findings underwent a thorough
deliberative process to develop meaningful and effective recommendations.
Details
Project Status:
Completed
URL for project:
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/reanimation-en-contexte-de-surdose-dopioides-dans-la-communaute.html
Year Published:
2023
URL for published report:
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/reanimation-en-contexte-de-surdose-dopioides-dans-la-communaute.html
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
Province:
Quebec
MeSH Terms
- Drug Overdose
- Cardiopulmonary Resuscitation
- Out-of-Hospital Cardiac Arrest
- Heart Arrest
- Naloxone
- Analgesics, Opioid
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.